Silver Book Fact

In the U.S., new cancer drugs have increased life expectancy at birth by 10.7%.

The Expanding Pharmaceutical Arsenal in the War on Cancer. Working Paper No. 10328 Web site. http://www.nber.org/papers/w10328. Published Feb. 2004

Reference

Title
The Expanding Pharmaceutical Arsenal in the War on Cancer
Publication
Working Paper No. 10328
Publisher
National Bureau of Economic Research
Publication Date
Published Feb. 2004
Authors
Lichtenberg, Frank R
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • “Knowing that his disease had a high cure rate, Ben Dacus felt a sense of security at a time of great uncertainty. In 1988 he was diagnosed with Hodgkin’s disease. Strangely…  
  • According to the Pharmaceutical Research and Manufacturers of America, a medicine in development targets late-stage metastatic melanoma. The medicine contains a gene encoding antigen that may be able to…  
  • A 2002 study found that image-guided percutaneous needle biopsies are between 3 and 7 times more cost-effective than open surgical biopsies, require a shorter procedure time, result in fewer infections,…  
  • The 1-year survival rate for lung cancer has increased from 37% in 1975 to 42% in 1999-2001, largely because of improvements to surgical techniques and with combined therapies.  
  • The 5-year survival rate for all cancers diagnosed between 1995 and 2001 is up from 50% in 1974-1976 to 65%.